NCT00148317 · OUTCOME

Yield of CD34+ Stem Cells

Phase II Study of Velcade, Decadron, and Doxil Followed by Cyclophosphamide in Multiple Myeloma · Source last updated 2017-07-18

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure: MEDIAN
Unit: 10^6 cells/kg
Interval / dispersion: Full Range
Time frame: Occurred after mobilization, and prior to Stem cell transplant; a 7 day limit was imposed on stem cell collection

What was measured

This is the yield of CD34+ stem cells collection after high dose cyclophosphamide.

Yield of stem cell collection for the group that underwent bortezomib-based Mobilization

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

Group	Source count
Treatment Arm - Post Bortezomib-based Mobilization	27

Source class 1

Values in 10^6 cells/kg · Interval/dispersion: Full Range
Group	Value	Spread	Lower	Upper	Comment
Treatment Arm - Post Bortezomib-based Mobilization	23.2	Not reported	6.8	294.2	Not reported

Complete source fields

classes

denoms

description

This is the yield of CD34+ stem cells collection after high dose cyclophosphamide.

dispersion Type

Full Range

groups

param Type

MEDIAN

reporting Status

POSTED

time Frame

Occurred after mobilization, and prior to Stem cell transplant; a 7 day limit was imposed on stem cell collection

title

Yield of CD34+ Stem Cells

type

SECONDARY

unit Of Measure

10^6 cells/kg

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice